AUPH
Aurinia Pharmaceuticals Inc
16.90$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 13.3% | 5.1% | 2.3% | 0.2% | 8,937.8% | 16,624.5% | 100.4% | 2.4% | 4.2% | 8.1% | 12.0% | 11.5% | |
| 86.7% | 94.9% | 97.7% | 99.8% | -8,837.8% | 100.0% | 100.0% | 97.6% | 95.8% | 91.9% | 88.0% | 88.5% | |
| 3,277.7% | 6,800.9% | 8,401.2% | 8,078.6% | 8,937.8% | 16,624.5% | 100.4% | 112.1% | 33.6% | 28.3% | 8.8% | 11.5% | |
| 2,478.4% | 2,665.1% | 4,028.9% | 2,880.0% | 2,953.3% | 7,024.5% | 194.1% | 375.9% | 146.5% | 111.1% | 67.2% | 34.8% | |
| 6,303.2% | 10,128.9% | 13,285.0% | 11,305.2% | 12,229.2% | 28,698.4% | 308.1% | 493.9% | 178.9% | 144.2% | 90.0% | 51.4% | |
| -6,216.5% | -10,034.0% | -13,187.3% | -11,205.5% | -12,129.2% | -28,598.4% | -208.1% | -396.3% | -83.2% | -52.2% | -2.0% | 37.1% | |
| 10.8% | 21.3% | 15.6% | 167.1% | 482.5% | 12.3% | 10.6% | 1.2% | 3.8% | 1.6% | 2.1% | 1.5% | |
| -5,988.1% | -7,917.9% | -13,465.3% | -16,855.2% | -13,833.0% | -27,748.7% | -205.1% | -395.1% | -79.3% | -44.1% | 3.2% | 40.3% | |
| 10.8% | -2,116.2% | 278.0% | 5,696.2% | 15.8% | 45.3% | -0.2% | 1.7% | 1.4% | 0.3% | 0.7% | -61.1% | |
| -5,988.1% | -7,917.9% | -13,465.3% | -16,855.2% | -13,848.8% | -27,794.0% | -204.9% | -396.8% | -80.7% | -44.5% | 2.4% | 101.5% | |
| -5,646.0% | -9,371.1% | -12,332.4% | -10,859.0% | -11,647.3% | -28,230.2% | -205.4% | -389.1% | -81.1% | -35.9% | 13.5% | 45.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.